Warning: The NCBI web site requires JavaScript to function. more...
Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.
Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM.
Breast Cancer Res. 2004;6(5):R499-513. Epub 2004 Jul 6. Erratum in: Breast Cancer Res. 2005;7(1):32.
Related citations
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
Breast Cancer Res. 2008;10(5):R87. Epub 2008 Oct 17.
A SAGE (serial analysis of gene expression) view of breast tumor progression.
Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K.
Cancer Res. 2001 Aug 1;61(15):5697-702.
The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.
Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE.
Cancer Res. 2002 Sep 15;62(18):5351-7.
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K.
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. Epub 2001 Jul 31.
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.
Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.
From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies.
Hu Y, Sun H, Drake J, Kittrell F, Abba MC, Deng L, Gaddis S, Sahin A, Baggerly K, Medina D, Aldaz CM.
Cancer Res. 2004 Nov 1;64(21):7748-55.
Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development.
Carlsson H, Petersson S, Enerbäck C.
Int J Oncol. 2005 Dec;27(6):1473-81.
Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer.
Zikan M, Bohm J, Pavlista D, Cibula D.
Clin Transl Oncol. 2011 Sep;13(9):652-5.
Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases.
Fujita M, Khazenzon NM, Bose S, Sekiguchi K, Sasaki T, Carter WG, Ljubimov AV, Black KL, Ljubimova JY.
Breast Cancer Res. 2005;7(4):R411-21. Epub 2005 Apr 6.
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H, Stephens LC, Kumar R.
Clin Cancer Res. 2006 Mar 1;12(5):1479-86.
Classification of ductal carcinoma in situ by gene expression profiling.
Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ.
Breast Cancer Res. 2006;8(5):R61.
Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
Schedin P, Borges V.
Breast Cancer Res. 2009;11(2):102. Epub 2009 Mar 26.
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F.
Mol Oncol. 2010 Aug;4(4):357-68. Epub 2010 Jun 26.
Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
Zhang GJ, Kimijima I, Abe R, Kanno M, Katagata N, Hara K, Watanabe T, Tsuchiya A.
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2329-35.
Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ.
Cancer Res. 2006 May 15;66(10):5278-86.
Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
Seth A, Kitching R, Landberg G, Xu J, Zubovits J, Burger AM.
Anticancer Res. 2003 May-Jun;23(3A):2043-51.
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z.
BMC Cancer. 2007 Mar 27;7:55.
Microdissection and SAGE as a combined tool to reveal gene expression in ductal carcinoma in situ of the breast.
Verlinden I, Janssens J, Raus J, Michiels L.
Mol Carcinog. 2004 Dec;41(4):197-206.
Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.
Kang JH, Kim SJ, Noh DY, Park IA, Choe KJ, Yoo OJ, Kang HS.
Lab Invest. 2001 Apr;81(4):573-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on